BEHAVIOURAL PHARMACOLOGY Journal

publication venue for

Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice. 36:579-587. 2025
Opioid receptor antagonists reduce motivated wheel-running behavior in mice. 35:114-121. 2024
Heterozygous and homozygous gene knockout of the 5-HT1B receptor have different effects on methamphetamine-induced behavioral sensitization. 34:393-403. 2023
Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. 26:345-352. 2015
Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment. 26:167-179. 2015
Methylone-induced hyperthermia and lethal toxicity. 26:345-352. 2015
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice. 25:158-165. 2014
Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. 19:566-574. 2008
Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. 15:387-395. 2004

category

International Standard Serial Number (ISSN)

0955-8810

Electronic International Standard Serial Number (EISSN)

1473-5849

journal abbreviation

BEHAV PHARMACOL